We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Yeast Protein Controls Prion Formation

By Biotechdaily staff writers
Posted on 09 Jun 2004
Researchers studying amyloid fibers, plaque-like proteins that form in the brains of individuals with Alzheimer's disease, have found a protein in yeast that can either prevent formation of the fibers under some conditions or dissolve them under others.

Investigators at the Whitehead Institute for Biomedical Research (Cambridge, MA, USA) worked with two yeast proteins, Sup35 and Hsp104. More...
When a critical level of Hsp104 was present in the cell, Sup35 formed into a self-perpetuating fibrous prion-like structure called PSI+. When Hsp104 was either absent or present in high levels, PSI+ did not form. These findings were published May 20, 2004, in the online edition of Science.

While a certain amount of Hsp104 was required for Sup35 to initiate prion formation, high levels caused the fibrous structures to change conformation and become soluble. "These proteins are remarkably stable,” said senior author Dr. Susan Lindquist, director of the Whitehead Institute. "This is the first time that anyone has found anything that can catalytically take apart an amyloid fiber. Given their resilient structure, the fact that a protein can take apart these amyloids is remarkable. It has huge implications for our understanding of the protein folding process in amyloid-related conditions.”




Related Links:
Whitehead Institute for Biomedical Research

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Aspiration System
VACUSAFE
New
Thyroid Test
Anti-Thyroid EIA Test
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.